Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FQ87G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,809
Award facts
- Contract value 100% obligated
- $19,809.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $19,809.17 for Zepbound 7.5 mg/0.5 mL pen injections on November 4, 2025, with completion scheduled for November 5, 2025. This competitively awarded, firm fixed price delivery order was executed without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026, which enables the contractor to deliver a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates capability in delivering specialized pharmaceuticals including diabetes medications, neurological treatments, and other therapeutic products through competitive delivery orders with firm fixed pricing. This delivery order for Zepbound, a GLP-1 receptor agonist used for weight management, reflects continued demand for diabetes and metabolic health medications within the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DB26FQ87G?
SPE2DB26FQ87G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DB26FQ87G worth?
The government has obligated $19,809 on SPE2DB26FQ87G.
Is contract SPE2DB26FQ87G an order under another contract?
Yes. SPE2DB26FQ87G is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB26FQ87G competed?
The extent of competition for SPE2DB26FQ87G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award